GH Secretagogue Protocol

Overview

Growth hormone (GH) secretagogues are peptides that stimulate the pituitary gland to produce and release endogenous growth hormone. Unlike exogenous GH administration (which provides synthetic growth hormone directly), secretagogues work with the body's own feedback mechanisms, prompting a more physiological pulsatile release pattern.

The most widely referenced secretagogue combination pairs a Growth Hormone Releasing Peptide (GHRP) with a Growth Hormone Releasing Hormone (GHRH) analog. The GHRP initiates the GH pulse, while the GHRH amplifies it — resulting in a synergistic effect that exceeds what either compound achieves alone.

This protocol focuses on the combination of Ipamorelin (a selective GHRP) and CJC-1295 without DAC (also known as Mod GRF 1-29, a GHRH analog), which is considered the most side-effect-friendly pairing in this class.

Compounds Involved

Why Ipamorelin?

Among GHRPs, Ipamorelin is notable for its selectivity. Unlike GHRP-6 or GHRP-2, Ipamorelin does not significantly increase cortisol, prolactin, or ghrelin-driven hunger. This makes it better tolerated and suitable for longer-term protocols.

CJC-1295 with DAC vs. Without DAC (Mod GRF 1-29)

• CJC-1295 with DAC has a Drug Affinity Complex that extends its half-life to several days. This produces a sustained but less pulsatile GH elevation, which some researchers find less desirable as it does not mimic natural GH release patterns.
• CJC-1295 without DAC (Mod GRF 1-29) has a short half-life of approximately 30 minutes, producing sharp, physiological GH pulses when combined with Ipamorelin. This is the preferred form for most secretagogue protocols.

Protocol Structure

Standard Protocol (Weeks 1–12)

Dosing:

• Ipamorelin: 100–300 mcg per injection
• Mod GRF 1-29: 100–300 mcg per injection
• Both peptides are typically drawn into the same syringe and administered together

Frequency: 1–3 times daily

Common timing windows:

Beginner Approach

For those new to secretagogues, a single daily injection before bed is the simplest starting point:

• Ipamorelin: 100 mcg
• Mod GRF 1-29: 100 mcg
• Timing: 30–60 minutes before sleep, on an empty stomach
• Duration: 8–12 weeks

Intermediate Approach

Twice-daily dosing captures more GH pulses:

• Morning (fasted): 200 mcg Ipamorelin + 200 mcg Mod GRF
• Pre-bed: 200 mcg Ipamorelin + 200 mcg Mod GRF
• Duration: 12 weeks, followed by a 4-week break

Advanced Approach

Three daily injections maximize GH output:

• Morning (fasted): 200–300 mcg each
• Post-workout: 200–300 mcg each
• Pre-bed: 200–300 mcg each
• Duration: 12–16 weeks with cycling

Fasted Administration

Fasted administration is a critical element of this protocol. Elevated blood glucose and insulin levels suppress GH release from the pituitary, significantly blunting the effect of secretagogues.

Guidelines for fasting around injections:

• No food for at least 2 hours before and 30 minutes after injection
• Water, black coffee, and plain tea are acceptable
• Avoid carbohydrates and fats especially — these are the strongest GH suppressors
• A small amount of protein (under 10g) is generally considered acceptable by most practitioners, though full fasting is preferred

Combining Peptides in One Syringe

Ipamorelin and Mod GRF 1-29 can be drawn from their respective vials into the same syringe for a single injection:

1. Draw the desired amount of Ipamorelin first
2. Then draw the desired amount of Mod GRF 1-29 into the same syringe
3. Administer as a single subcutaneous injection

This approach reduces injection frequency and is commonly practiced without reported compatibility issues.

Expected Timeline

Effects are gradual and cumulative. GH secretagogues do not produce the rapid, dramatic effects associated with supraphysiological exogenous GH doses.

Cycling

Continuous long-term use of GH secretagogues may lead to pituitary desensitization — a reduced response over time. Cycling helps preserve receptor sensitivity.

Common cycling patterns:

• 12 weeks on / 4 weeks off
• 5 days on / 2 days off (weekdays only)
• 8 weeks on / 4 weeks off for beginners

For detailed cycling strategies, see Peptide Cycling.

Important Considerations

• Blood glucose management: Those with insulin resistance or metabolic conditions should be aware that GH elevation can affect glucose metabolism. Monitoring is advisable.
• Cortisol interaction: While Ipamorelin has minimal cortisol impact, timing the morning dose during the natural cortisol peak (shortly after waking) is intentional.
• Stacking with other peptides: GH secretagogues are commonly combined with recovery peptides like BPC-157 and TB-500. When stacking, administer secretagogues separately and maintain fasting windows.
• Not a substitute for sleep: The pre-bed dose amplifies the natural sleep-related GH pulse, but poor sleep hygiene will still impair GH output regardless of peptide use.
• Age considerations: Natural GH production declines with age. Older individuals may experience more pronounced subjective effects from secretagogue protocols.

Disclaimer

This article is for educational and informational purposes only. It does not constitute medical advice, and no therapeutic claims are made. Peptide research is ongoing, and individual outcomes may vary. Consult a qualified healthcare professional before beginning any peptide protocol. All compounds discussed are intended for research purposes.